Expand APRE Menu

APRE Stock Summary and Trading Ideas (Aprea Therapeutics | NASDAQ:APRE)

Charts for Today's Stock Price and Implied Volatility in Aprea Therapeutics


Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for APRE by Theoretical Edge and Win Rates


Trading Statistics

Key Ratios

Aprea Therapeutics (APRE) Frequently Asked Questions

What does Aprea Therapeutics do?

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).

What symbol and exchange does Aprea Therapeutics stock trade?

Aprea Therapeutics trades on the NASDAQ stock market under the symbol APRE.

What is Aprea Therapeutics stock price doing today?

As of March 22, 2023, APRE stock price declined to $4.82 with 16,219 million shares trading.

What is Aprea Therapeutics's Beta?

APRE has a beta of 0.97, meaning it tends to be less sensitive to market movements. APRE has a correlation of 0.03 to the broad based SPY ETF.

How much is Aprea Therapeutics worth?

APRE has a market cap of $17.99 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Aprea Therapeutics traded in the last 3 year period?

In the last 3 years, APRE stock traded as high as $822.30 and as low as $.47.

What are the top ETFs holding Aprea Therapeutics?

The top ETF exchange traded funds that APRE belongs to (by Net Assets): VXF, VTI, ITOT.

Is Aprea Therapeutics (APRE) a good investment?

APRE has underperformed the market in the last year with a price return of -86.8% while the SPY ETF lost -11.3%. APRE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -32.5% and -2.2%, respectively, while the SPY returned +3.4% and -1.3%, respectively.

What is the support and resistance for Aprea Therapeutics (APRE) stock price?

APRE support price is $4.71 and resistance is $5.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APRE stock will trade within this expected range on the day.